These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 32282877)

  • 1. Two-part joint model for a longitudinal semicontinuous marker and a terminal event with application to metastatic colorectal cancer data.
    Rustand D; Briollais L; Tournigand C; Rondeau V
    Biostatistics; 2022 Jan; 23(1):50-68. PubMed ID: 32282877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bayesian estimation of two-part joint models for a longitudinal semicontinuous biomarker and a terminal event with INLA: Interests for cancer clinical trial evaluation.
    Rustand D; van Niekerk J; Rue H; Tournigand C; Rondeau V; Briollais L
    Biom J; 2023 Apr; 65(4):e2100322. PubMed ID: 36846925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of longitudinal semicontinuous data using marginalized two-part model.
    Jaffa MA; Gebregziabher M; Garrett SM; Luttrell DK; Lipson KE; Luttrell LM; Jaffa AA
    J Transl Med; 2018 Nov; 16(1):301. PubMed ID: 30400798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shared parameter and copula models for analysis of semicontinuous longitudinal data with nonrandom dropout and informative censoring.
    Jaffa MA; Gebregziabher M; Jaffa AA
    Stat Methods Med Res; 2022 Mar; 31(3):451-474. PubMed ID: 34806502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Joint model for left-censored longitudinal data, recurrent events and terminal event: Predictive abilities of tumor burden for cancer evolution with application to the FFCD 2000-05 trial.
    Król A; Ferrer L; Pignon JP; Proust-Lima C; Ducreux M; Bouché O; Michiels S; Rondeau V
    Biometrics; 2016 Sep; 72(3):907-16. PubMed ID: 26890381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bayesian inference for two-part mixed-effects model using skew distributions, with application to longitudinal semicontinuous alcohol data.
    Xing D; Huang Y; Chen H; Zhu Y; Dagne GA; Baldwin J
    Stat Methods Med Res; 2017 Aug; 26(4):1838-1853. PubMed ID: 26092477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonparametric Bayesian functional two-part random effects model for longitudinal semicontinuous data analysis.
    Park J; Choi T; Chung Y
    Biom J; 2021 Apr; 63(4):787-805. PubMed ID: 33554393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling zero-modified count and semicontinuous data in health services research Part 1: background and overview.
    Neelon B; O'Malley AJ; Smith VA
    Stat Med; 2016 Nov; 35(27):5070-5093. PubMed ID: 27500945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A marginalized two-part model for semicontinuous data.
    Smith VA; Preisser JS; Neelon B; Maciejewski ML
    Stat Med; 2014 Dec; 33(28):4891-903. PubMed ID: 25043491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A marginalized two-part model for longitudinal semicontinuous data.
    Smith VA; Neelon B; Preisser JS; Maciejewski ML
    Stat Methods Med Res; 2017 Aug; 26(4):1949-1968. PubMed ID: 26156962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Joint frailty models for zero-inflated recurrent events in the presence of a terminal event.
    Liu L; Huang X; Yaroshinsky A; Cormier JN
    Biometrics; 2016 Mar; 72(1):204-14. PubMed ID: 26295794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling zero-modified count and semicontinuous data in health services research part 2: case studies.
    Neelon B; O'Malley AJ; Smith VA
    Stat Med; 2016 Nov; 35(27):5094-5112. PubMed ID: 27500973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A likelihood-based two-part marginal model for longitudinal semicontinuous data.
    Su L; Tom BD; Farewell VT
    Stat Methods Med Res; 2015 Apr; 24(2):194-205. PubMed ID: 21873302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study.
    Tournigand C; André T; Achille E; Lledo G; Flesh M; Mery-Mignard D; Quinaux E; Couteau C; Buyse M; Ganem G; Landi B; Colin P; Louvet C; de Gramont A
    J Clin Oncol; 2004 Jan; 22(2):229-37. PubMed ID: 14657227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-part joint modeling methods for complex functional data mixed with zero-and-one-inflated proportions and zero-inflated continuous outcomes with skewness.
    Li H; Staudenmayer J; Wang T; Keadle SK; Carroll RJ
    Stat Med; 2018 Feb; 37(4):611-626. PubMed ID: 29052239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Joint model robustness compared with the time-varying covariate Cox model to evaluate the association between a longitudinal marker and a time-to-event endpoint.
    Arisido MW; Antolini L; Bernasconi DP; Valsecchi MG; Rebora P
    BMC Med Res Methodol; 2019 Dec; 19(1):222. PubMed ID: 31795933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling Semicontinuous Longitudinal Expenditures: A Practical Guide.
    Smith VA; Maciejewski ML; Olsen MK
    Health Serv Res; 2018 Aug; 53 Suppl 1(Suppl Suppl 1):3125-3147. PubMed ID: 29315527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Joint modeling of longitudinal data with informative cluster size adjusted for zero-inflation and a dependent terminal event.
    Shen B; Chen C; Liu D; Datta S; Ghahramani N; Chinchilli VM; Wang M
    Stat Med; 2021 Sep; 40(21):4582-4596. PubMed ID: 34057216
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.